•
Sep 30, 2020

22nd Century Group Q3 2020 Earnings Report

22nd Century Group's Q3 2020 results were announced, featuring a revenue increase and reduced net loss compared to the previous year.

Key Takeaways

22nd Century Group reported a 13.1% increase in net sales revenue to $7.3 million for the third quarter of 2020 compared to the same period in 2019. The company's net loss improved by $6.0 million, and its financial position remains strong with $26.8 million in cash, cash equivalents, and short-term investment securities.

Net sales revenue increased by 13.1% compared to Q3 2019, reaching $7.3 million.

The company is focused on securing MRTP authorization from the FDA for VLN.

Operating expenses improved by $3.2 million, and operating loss improved by $3.6 million compared to the prior-year quarter.

Net loss improved by $6.0 million compared to the same quarter in the prior year.

Total Revenue
$7.3M
Previous year: $6.46M
+13.0%
EPS
-$7.2
Previous year: -$19.2
-62.5%
Adjusted EBITDA
-$3.41M
Previous year: -$4.63M
-26.4%
Cash and Equivalents
$26.8M
Previous year: $618K
+4238.1%

22nd Century Group

22nd Century Group